For the quarter ending 2025-09-30, LCTX made $3,681,000 in revenue. -$29,781,000 in net income. Net profit margin of -809.05%.
| Income Statement | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 |
|---|---|---|---|---|
| Total revenues | 3,681,000 | 2,765,000 | 1,502,000 | 1,906,666.667 |
| Cost of royalties | 5,000 | 39,000 | - | - |
| Research and development | 3,271,000 | 3,106,000 | 3,114,000 | 3,100,333.333 |
| General and administrative | 4,191,000 | 4,560,000 | 4,857,000 | 4,587,000 |
| Cost of sales | - | - | 36,000 | 98,666.667 |
| Loss on impairment of intangible asset (note 6 and note 13) | 0 | 14,840,000 | - | - |
| Total operating expenses | 7,467,000 | 22,545,000 | 8,007,000 | 7,786,000 |
| Loss from operations | -3,786,000 | -19,780,000 | -6,505,000 | -5,879,333.333 |
| Interest income, net | 366,000 | 454,000 | 478,000 | 560,833.333 |
| Gain (loss) on marketable equity securities, net | 6,000 | -2,000 | -5,000 | -666.667 |
| Change in fair value of warrant liability | 26,557,000 | 12,740,000 | -2,305,000 | -532,000 |
| Foreign currency transaction gain (loss), net | 219,000 | 1,678,000 | -231,000 | -239,000 |
| Other income (expense), net | 0 | 26,000 | -185,000 | -167,500 |
| Loss before income taxes | - | - | - | -5,193,666.667 |
| Total other income (expenses) | -25,966,000 | -10,584,000 | 2,362,000 | 685,666.667 |
| Net loss | -29,752,000 | -30,364,000 | -4,143,000 | -5,193,666.667 |
| Net (income) loss attributable to noncontrolling interest | 29,000 | 100,000 | -4,000 | -2,000 |
| Net loss attributable to lineage | -29,781,000 | -30,464,000 | -4,139,000 | -5,191,666.667 |
| Basic net loss per share | -0.13 | -0.13 | -0.02 | -0.023 |
| Diluted net loss per share | -0.13 | -0.13 | -0.02 | -0.023 |
| Weighted average number of shares outstanding, basic, total | 228,853,000 | 228,356,000 | 226,054,000 | 3,786,000 |
| Weighted average number of shares outstanding, diluted | 228,853,000 | 228,356,000 | 226,054,000 | 3,786,000 |
Lineage Cell Therapeutics, Inc. (LCTX)
Lineage Cell Therapeutics, Inc. (LCTX)